1995 Jonathan E. Rhoads Lecture. The Nutrition Management of the Patient With Acute Renal Failure
- 1 January 1996
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 20 (1) , 3-12
- https://doi.org/10.1177/014860719602000103
Abstract
The clinical status of patients with acute renal failure (ARF) varies greatly. Some individuals have only mild or moderate ARF or may have only mild perturbations of their metabolic status. Other patients exhibit a severe reduction in renal function with oliguria or anuria. Depending upon their comorbid conditions, ARF patients may be among the most hypercatabolic patients in the hospital. Clinical trials have not clearly shown a beneficial effect of nutrition support on morbidity or mortality in patients with ARF, although limitations in sample size and experimental design and inclusion of patients with widely disparate clinical conditions may have contributed to the difficulty in demonstrating benefits. Several recent therapeutic approaches that have been studied either in experimental animals with ARF or in small numbers of humans with ARF hold promise for improving clinical outcome. Continuous arteriovenous or venovenous hemofiltration with or without dialysis is such a therapy. In comparison to intermittent hemodialysis this former treatment more safely removes large quantities of water and solutes from critically ill patients with unstable hemodynamics and allows them to receive rather large quantities of nutrients, including amino acids. Also promising are studies in experimental animals with ARF which indicate that several growth factors may accelerate the recovery of renal function. In rats with ARF, insulin‐like growth factor 1 both enhances recovery of renal function and suppresses their enhanced catabolism. For most patients with ARF requiring nutrition support, evidence suggests that both essential and nonessential amino acids should be employed. However, there appears to be a therapeutic role for small quantities of essential amino acids, without nonessential amino acids, in selected patients. Data support the importance of proactive measures to prevent fluid and electrolyte imbalances in patients with ARF. (Journal of Parenteral and Enteral Nutrition 20:3–12, 1996)Keywords
This publication has 56 references indexed in Scilit:
- Very large-scale, randomized, clinical trials in sepsis and septic shockCritical Care Medicine, 1994
- Therapy with Antibody to Tumor Necrosis Factor in SepsisClinical Infectious Diseases, 1993
- Total Parenteral Nutrition With Glutamine in Bone Marrow Transplantation and Other Clinical Applications (A Randomized, Double‐Blind Study)Journal of Parenteral and Enteral Nutrition, 1993
- Arginine-Supplemented Diets Improve Survival in Gut-Derived Sepsis and Peritonitis by Modulating Bacterial Clearance The Role of Nitric OxideAnnals of Surgery, 1993
- Amino acid losses during continuous high-flux hemofiltration in the critically ill patientCritical Care Medicine, 1989
- Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats.Journal of Clinical Investigation, 1989
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failureKidney International, 1987
- Amino acid losses during hemodialysis with infusion of amino acids and glucoseKidney International, 1982
- The Morphology of “Acute Tubular Necrosis” in ManMedicine, 1979